RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/21714539http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/21714539http://www.w3.org/2000/01/rdf-schema#comment"For proof-of-concept of halogen bonding in drug design, a series of halogenated compounds were designed based on a lead structure as new inhibitors of phosphodiesterase type 5. Bioassay results revealed a good correlation between the measured bioactivity and the calculated halogen bond energy. Our X-ray crystal structures verified the existence of the predicted halogen bonds, demonstrating that the halogen bond is an applicable tool in drug design and should be routinely considered in lead optimization."xsd:string
http://purl.uniprot.org/citations/21714539http://purl.org/dc/terms/identifier"doi:10.1021/jm200644r"xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/author"Chen T."xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/author"Liu Z."xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/author"Jiang H."xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/author"Lu Y."xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/author"Shen J."xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/author"Shi J."xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/author"Tian G."xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/author"Wang G."xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/author"Wang S."xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/author"Wang Z."xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/author"Wang X."xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/author"Xu Y."xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/author"Xu Z."xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/author"Yan X."xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/author"Zhu W."xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/author"Chen K."xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/author"Chen T.'"xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/date"2011"xsd:gYear
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/name"J Med Chem"xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/pages"5607-5611"xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/title"Utilization of halogen bond in lead optimization: a case study of rational design of potent phosphodiesterase type 5 (PDE5) inhibitors."xsd:string
http://purl.uniprot.org/citations/21714539http://purl.uniprot.org/core/volume"54"xsd:string